ITGAM and breast cancer: Both CD11b KO and CD18dim neutrophils killed the tumor cells tested (LLC lung carcinoma, AT3 breast cancer, 4T1 breast cancer and B16-F10 melanoma cells) as efficiently as wild-type neutrophils (unpublished data).